Order Article Reprints

Páez-Franco JC, Zermeño-Ortega MR, de la O-Contreras CM, Canseco-González D, Parra-Unda JR, Avila-Sorrosa A, Enríquez RG, Germán-Acacio JM, Morales-Morales D. Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment. Pharmaceutics. 2022; 14(2):402. https://doi.org/10.3390/pharmaceutics14020402

Páez-Franco, José C., Miriam R. Zermeño-Ortega, Carmen Myriam de la O-Contreras, Daniel Canseco-González, Jesus R. Parra-Unda, Alcives Avila-Sorrosa, Raúl G. Enríquez, Juan M. Germán-Acacio, and David Morales-Morales. 2022. "Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment" Pharmaceutics 14, no. 2: 402. https://doi.org/10.3390/pharmaceutics14020402

Páez-Franco, J. C., Zermeño-Ortega, M. R., de la O-Contreras, C. M., Canseco-González, D., Parra-Unda, J. R., Avila-Sorrosa, A., Enríquez, R. G., Germán-Acacio, J. M., & Morales-Morales, D. (2022). Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment. Pharmaceutics, 14(2), 402. https://doi.org/10.3390/pharmaceutics14020402